New and Emerging LDL Cholesterol–Lowering Drugs
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference48 articles.
1. . Optimal low-density lipoprotein is 50 to 70 mgdl: lower is better and physiologically normal.;OKeefe;J Am Coll Cardiol,2004
2. . Intensive lipid lowering with atorvastatin in patients with stable coronary disease.;LaRosa;N Engl J Med,2005
3. What the statin trials have taught us.;Waters;Am J Cardiol,2006
4. . Implications of recent clinical trials for the National cholesterol Education Program Adult treatment Panel III guidelines.;Grundy;Circulation,2004
5. . Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users.;Cohen;J Clin Lipidol,2012
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of PCSK9 inhibitors in the management of dyslipidaemia;Indian Heart Journal;2024-03
2. The promising novel therapies for familial hypercholesterolemia;Journal of Clinical Laboratory Analysis;2022-06-17
3. ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review;Progress in Lipid Research;2020-01
4. Novel lipid-modifying therapies addressing unmet needs in cardiovascular disease;World Journal of Cardiology;2019-11-26
5. Synthesis and Evaluation of 2-Azetidinone and 1H-Pyrrole-2,5-dione Derivatives as Cholesterol Absorption Inhibitors for Reducing Inflammation Response and Oxidative Stress;Chemistry & Biodiversity;2019-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3